Vetoquinol corporate brochure 2017

2 MAIN MARKETS Vetoquinol relies on a clear and effec- tive organisation structure adapted to the two main animal health markets: livestock and pets. These two markets are distinguished by their marketing approaches and the needs of their final customers, namely livestock breeders and pet owners. > Livestock Increasing demand for animal pro- teins is spurring livestock profession- als worldwide to improve productiv- ity while fully ensuring the health of their animals. Be it in the production of milk, beef or pork, Vetoquinol with its veterinary network provides advice, products and services in response to the challenges faced by livestock professionals. > For pets: The pet segment is characterised by moderate growth in mature econo- mies and strong growth potential in countries with growing econo- mies. Commensurate with the unique emotional relationships between owners and their pets, Vetoquinol has developed products blending efficacy and ease of administration. The specific offer proposed to each of these two markets is the result of team work, involving country representa- tives liaising continuously with their customers and the Group functions. 4 STRATEGIC SPECIES To optimise R&D and marketing, the Group focuses on four key species: dogs, cats, cattle and pigs. RIGOROUS CHOICES IN PATHOLOGIES AND PRODUCTS Vetoquinol specifies its future prod- ucts in line with market needs, trends, the intensity of the competition and the expectations of customers. The offer for pets comprises anti- infection products; treatments for pain and inflammation, behaviour, urinary incontinence, liver diseas- es, cardio-nephrology, external and internal anti-parasitics; and care and hygiene products. For livestock, major emphasis is placed on anti-infection products to address the main respiratory, digestive, loco- motor, reproductive and udder diseases, and on the corresponding anti-inflam- matory treatments. This offer is rounded off by a reproduction range and coun- try-specific products. > Infectious diseases Vetoquinol, a creator of innovative antibiotics, has established itself as a European leader in anti-infection products, promoting the rational use of antibiotics. Forcyl ® , an anti-infec- tion treatment for livestock, highlights the Group’s commitment through the SISAAB (Singe Action Short Acting Antibiotic) concept, or how to effec- UNE DYNAMIQUE DE CROISSANCE Engaged by our product strategy 8 Vetoquinol is a partner to veterinarians, helping them to propose effective solutions to pet owners and livestock professionals. The Group responds to today’s principle health problems and offers a range of increasingly effective products and services adapted continuously to changes in customer needs. GROWTH MOMENTUM